Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial
Blauvelt, Andrew, MD, MBA, Papp, Kim A., MD, PhD, Griffiths, Christopher E.M., MD, Randazzo, Bruce, MD, PhD, Wasfi, Yasmine, MD, PhD, Shen, Yaung-Kaung, PhD, Li, Shu, PhD, Kimball, Alexa B., MPH, MD
Published in Journal of the American Academy of Dermatology (01.03.2017)
Published in Journal of the American Academy of Dermatology (01.03.2017)
Get full text
Journal Article
Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials
Reich, Kristian, Prof, Papp, Kim A, MD, Blauvelt, Andrew, MD, Tyring, Stephen K, Prof, Sinclair, Rodney, Prof, Thaçi, Diamant, Prof, Nograles, Kristine, MD, Mehta, Anish, BA, Cichanowitz, Nicole, MSJ, Li, Qing, PhD, Liu, Kenneth, PhD, La Rosa, Carmen, MD, Green, Stuart, MD, Kimball, Alexa B, Prof
Published in The Lancet (British edition) (15.07.2017)
Published in The Lancet (British edition) (15.07.2017)
Get full text
Journal Article
Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics
Mease, Philip J., MD, Gladman, Dafna D., MD, Papp, Kim A., MD, PhD, Khraishi, Majed M., MD, Thaçi, Diamant, MD, Behrens, Frank, MD, Northington, Robert, PhD, Fuiman, Joanne, MS, Bananis, Eustratios, PhD, Boggs, Robert, PhD, Alvarez, Daniel, MD
Published in Journal of the American Academy of Dermatology (01.11.2013)
Published in Journal of the American Academy of Dermatology (01.11.2013)
Get full text
Journal Article
Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2)
Crowley, Jeffrey, MD, Thaçi, Diamant, MD, Joly, Pascal, MD, Peris, Ketty, MD, Papp, Kim A., MD, PhD, Goncalves, Joana, MD, Day, Robert M., PhD, Chen, Rongdean, PhD, Shah, Kamal, MD, Ferrándiz, Carlos, MD, Cather, Jennifer C., MD
Published in Journal of the American Academy of Dermatology (01.08.2017)
Published in Journal of the American Academy of Dermatology (01.08.2017)
Get full text
Journal Article
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
Leonardi, Craig L, Prof, Kimball, Alexa B, MD, Papp, Kim A, MD, Yeilding, Newman, MD, Guzzo, Cynthia, MD, Wang, Yuhua, PhD, Li, Shu, MS, Dooley, Lisa T, DrPH, Gordon, Kenneth B, Dr
Published in The Lancet (British edition) (17.05.2008)
Published in The Lancet (British edition) (17.05.2008)
Get full text
Journal Article
Short and long-term safety outcomes with ixekizumab from 7 clinical trials in psoriasis: Etanercept comparisons and integrated data
Strober, Bruce, MD, PhD, Leonardi, Craig, MD, Papp, Kim A., MD, PhD, FRCPC, Mrowietz, Ulrich, MD, Ohtsuki, Mamitaro, MD, PhD, Bissonnette, Robert, MD, MSc, FRCPC, Ferris, Laura K., MD, PhD, Paul, Carle, MD, PhD, Lebwohl, Mark, MD, FAAD, Braun, Daniel K., MD, PhD, Mallbris, Lotus, MD, PhD, Wilhelm, Stefan, MD, Xu, Wen, PhD, Ljungberg, Anders, MD, Acharya, Nayan, MBBS, MRCP, MFPM, Reich, Kristian, MD, PhD
Published in Journal of the American Academy of Dermatology (01.03.2017)
Published in Journal of the American Academy of Dermatology (01.03.2017)
Get full text
Journal Article
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study
Papp, Kim A., MD, PhD, Krueger, James G., MD, PhD, Feldman, Steven R., MD, PhD, Langley, Richard G., MD, Thaci, Diamant, MD, Torii, Hideshi, MD, PhD, Tyring, Stephen, MD, PhD, Wolk, Robert, MD, PhD, DSc, Gardner, Annie, MS, Mebus, Charles, PhD, Tan, Huaming, PhD, Luo, Yingchun, PhD, Gupta, Pankaj, PhD, Mallbris, Lotus, MD, PhD, Tatulych, Svitlana, MD
Published in Journal of the American Academy of Dermatology (01.05.2016)
Published in Journal of the American Academy of Dermatology (01.05.2016)
Get full text
Journal Article
Clinical meaningfulness of complete skin clearance in psoriasis
Strober, Bruce, MD, PhD, Papp, Kim A., MD, PhD, Lebwohl, Mark, MD, Reich, Kristian, MD, Paul, Carle, MD, PhD, Blauvelt, Andrew, MD, Gordon, Kenneth B., MD, Milmont, Cassandra E., PhD, Viswanathan, Hema N., PhD, Li, Joanne, PhD, Pinto, Lionel, PhD, Harrison, David J., PhD, Kricorian, Greg, MD, Nirula, Ajay, MD, PhD, Klekotka, Paul, MD, PhD
Published in Journal of the American Academy of Dermatology (01.07.2016)
Published in Journal of the American Academy of Dermatology (01.07.2016)
Get full text
Journal Article
Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): Results from analyses of infections and malignancy from pooled phase II and III clinical trials
Gordon, Kenneth B., MD, Papp, Kim A., MD, Langley, Richard G., MD, Ho, Vincent, MD, Kimball, Alexa B., MD, Guzzo, Cynthia, MD, Yeilding, Newman, MD, Szapary, Philippe O., MD, MSCE, Fakharzadeh, Steven, MD, PhD, Li, Shu, MS, Hsu, Ming-Chun, PhD, Reich, Kristian, MD
Published in Journal of the American Academy of Dermatology (01.05.2012)
Published in Journal of the American Academy of Dermatology (01.05.2012)
Get full text
Journal Article
Five-year analysis from the ESPRIT 10-year postmarketing surveillance registry of adalimumab treatment for moderate to severe psoriasis
Menter, Alan, MD, Thaçi, Diamant, MD, Papp, Kim A., MD, Wu, Jashin J., MD, Bereswill, Mareike, MS, Teixeira, Henrique D., PhD, Rubant, Simone, PhD, Williams, David A., MD
Published in Journal of the American Academy of Dermatology (01.09.2015)
Published in Journal of the American Academy of Dermatology (01.09.2015)
Get full text
Journal Article
Impact of weight on the efficacy and safety of ustekinumab in patients with moderate to severe psoriasis: Rationale for dosing recommendations
Lebwohl, Mark, MD, Yeilding, Newman, MD, Szapary, Philippe, MD, Wang, Yuhua, PhD, Li, Shu, MS, Zhu, Yaowei, PhD, Reich, Kristian, MD, Langley, Richard G., MD, Papp, Kim A., MD
Published in Journal of the American Academy of Dermatology (01.10.2010)
Published in Journal of the American Academy of Dermatology (01.10.2010)
Get full text
Journal Article
Integrated safety analysis: Short- and long-term safety profiles of etanercept in patients with psoriasis
Pariser, David M., MD, Leonardi, Craig L., MD, Gordon, Kenneth, MD, Gottlieb, Alice B., MD, PhD, Tyring, Stephen, MD, PhD, Papp, Kim A., MD, Li, Joanne, PhD, Baumgartner, Scott W., MD
Published in Journal of the American Academy of Dermatology (01.08.2012)
Published in Journal of the American Academy of Dermatology (01.08.2012)
Get full text
Journal Article
Assessment of the long-term safety and effectiveness of etanercept for the treatment of psoriasis in an adult population
Papp, Kim A., MD, PhD, Poulin, Yves, MD, Bissonnette, Robert, MD, Bourcier, Marc, MD, Toth, Darryl, MD, Rosoph, Leslie, MD, Poulin-Costello, Melanie, BMath, MSc, Pstat, Setterfield, Mike, MSc, Syrotuik, Jerry, MA
Published in Journal of the American Academy of Dermatology (01.02.2012)
Published in Journal of the American Academy of Dermatology (01.02.2012)
Get full text
Journal Article
Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: Efficacy and safety results from an open-label study
Strober, Bruce E., MD, PhD, Poulin, Yves, MD, Kerdel, Francisco A., MD, Langley, Richard G., MD, Gu, Yihua, MS, Gupta, Shiraz R., PharmD, MPH, Okun, Martin M., MD, PhD, Papp, Kim A., MD, PhD
Published in Journal of the American Academy of Dermatology (01.04.2011)
Published in Journal of the American Academy of Dermatology (01.04.2011)
Get full text
Journal Article
Single-blind, randomized controlled trial evaluating the treatment of facial seborrheic dermatitis with hydrocortisone 1% ointment compared with tacrolimus 0.1% ointment in adults
Papp, Kim A., MD, PhD, FRCPC, Papp, Alexine, BA, Dahmer, Betty, RN, Clark, Christina S., MSc
Published in Journal of the American Academy of Dermatology (01.07.2012)
Published in Journal of the American Academy of Dermatology (01.07.2012)
Get full text
Journal Article